Blossom Pharmaceuticals FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Apr 11, 2025
  • No warning letters matched by name
Inspections 3 1 OAI
Recalls 13 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Blossom Pharmaceuticals has 13 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Blossom Pharmaceuticals" is on file. FDA has published 1 Form 483 for Blossom Pharmaceuticals.

What these totals cover: FDA records filed under the name "Blossom Pharmaceuticals".

Latest recall
D-0210-2026 · Class II · Oct 31, 2025
Latest inspection
Apr 11, 2025 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls13Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections3Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Blossom Pharmaceuticals's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Blossom Pharmaceuticals: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (1 OAI), 0 warning letters, 13 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
2025110130
202400000
202300000
202200000
202100000
202000000
201910000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Blossom Pharmaceuticals as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Blossom Pharmaceuticals yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Blossom Pharmaceuticals Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Apr 11, 2025 · Document on fda.gov 4833010806039

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

13 recall records on Oct 31, 2025.

NumberClassProductDate
D-0210-2026Class IIGlobe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals…Oct 31, 2025
D-0203-2026Class IIWecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation…Oct 31, 2025
D-0206-2026Class IINivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz…Oct 31, 2025
D-0201-2026Class IILanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street…Oct 31, 2025
D-0212-2026Class IIGlobe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by…Oct 31, 2025
D-0204-2026Class IIDynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation…Oct 31, 2025
D-0209-2026Class IINivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals…Oct 31, 2025
D-0208-2026Class IINivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA…Oct 31, 2025
D-0205-2026Class IIWeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex…Oct 31, 2025
D-0211-2026Class IIGlobe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta…Oct 31, 2025
D-0207-2026Class IIDynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street…Oct 31, 2025
D-0213-2026Class IIWecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street…Oct 31, 2025
D-0202-2026Class IIDynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10…Oct 31, 2025

Recent FDA inspections

3 inspections from Dec 16, 2016 to Apr 11, 2025.

DateSiteProductClassificationFEI
Apr 11, 2025Bardej, Goa, IndiaDrugsOfficial Action Indicated (OAI)3010806039
Feb 14, 2019Bardej, Goa, IndiaDrugsVoluntary Action Indicated (VAI)3010806039
Dec 16, 2016Bardej, Goa, IndiaDrugsVoluntary Action Indicated (VAI)3010806039
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3010806039Bardej, Goa, India3Apr 11, 2025

Blossom Pharmaceuticals and the FDA: common questions

Has Blossom Pharmaceuticals received an FDA warning letter?

No FDA warning letter addressed to the name "Blossom Pharmaceuticals" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Blossom Pharmaceuticals received an FDA Form 483?

FDA has published 1 Form 483 for Blossom Pharmaceuticals in its reading room, the most recent dated Apr 11, 2025. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Blossom Pharmaceuticals?

The most recent FDA inspection on file ended Apr 11, 2025 at Bardej, Goa, India and was classified OAI. FDA has 3 inspections of Blossom Pharmaceuticals on file, 1 of them classified OAI (official action indicated).

Has Blossom Pharmaceuticals had an FDA recall?

Yes. Blossom Pharmaceuticals has 13 FDA recalls on record. The most recent started Oct 31, 2025.

Need more than this page shows? Ask about Blossom Pharmaceuticals in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.